Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Block Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover trades at least twice the size of a fund's median trade that quarter
Fund Signals
Daily bullish and bearish fund signals, and how past ones played out
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Fund Flows Report
Our quarterly report on what the world’s largest funds bought and sold
Thematic Trends
Track which investment themes funds are piling into or pulling out of
Institutional Conviction Index
Stock index based on fund manager consensus updated each quarter
English
Deutsch
Español
Português
日本語
한국어
繁體中文
Sign in Sign up
English
Deutsch
Español
Português
日本語
한국어
繁體中文
We are live on ! Find out more
BIIB icon

Biogen
BIIB
Market cap $36.9B

Overview Fund Trends Fund Holders
249.59 USD
+2.46
1%
At close Updated Nov 20, 4:00 PM EST
Pre-market
After hours
249.28
-0.31
0.12%
1 day
1%
5 days
-2.22%
1 month
2.67%
3 months
16.44%
6 months
32.9%
Year to date
40.36%
1 year
48.41%
5 years
-1.04%
10 years
-21.59%

1,086 hedge funds and large institutions have $40.8B invested in Biogen in 2019 Q1 according to their latest regulatory filings, with 119 funds opening new positions, 391 increasing their positions, 436 reducing their positions, and 164 closing their positions.

New
Increased
Maintained
Reduced
Closed
2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3 2013 Q2

0.46% more ownership

Funds ownership: 87.27% → 87.73% (+0.46%)

5% less funds holding

Funds holding: 1,142 → 1,086 (-56)

10% less call options, than puts

Call options by funds: $1.15B | Put options by funds: $1.28B

10% less repeat investments, than reductions

Existing positions increased: 391 | Existing positions reduced: 436

18% less capital inflows, than outflows

Capital inflows: $4.41B | Capital outflows: $5.4B

24% less funds holding in top 10

Funds holding in top 10: 29 → 22 (-7)

27% less first-time investments, than exits

New positions opened: 119 | Existing positions closed: 164

Holders
1,086
Holders Change
-56
Holders Change %
-4.9%
% of All Funds
23.43%
Holding in Top 10
22
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-24.14%
% of All Funds
0.47%
New
119
Increased
391
Reduced
436
Closed
164
Calls
$1.15​B
Puts
$1.28​B
Net Calls
-⁠$132​M
Net Calls Change
+$215​M

Top Buyers

Rank Fund Capital Flow
1
AQR Capital Management
AQR Capital Management
Greenwich, Connecticut
+$335M
2
Capital World Investors
Capital World Investors
Los Angeles, California
+$279M
3
Deutsche Bank
Deutsche Bank
Frankfurt Am Main Ge, Germany
+$275M
4
Boston Partners
Boston Partners
Boston, Massachusetts
+$235M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$205M

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minneapolis, Minnesota
-$509M
2
Fidelity Investments
Fidelity Investments
Boston, Massachusetts
-$352M
3
JP Morgan Chase
JP Morgan Chase
New York
-$277M
4
VOYA Investment Management
VOYA Investment Management
Atlanta, Georgia
-$256M
5
OrbiMed
OrbiMed
New York
-$235M

BIIB Hedge Fund Activity: Q1 2019 in Review

1,086 of the 4,635 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q1 2019, worth a combined $40.8B — down 23% from $52.9B a quarter earlier.

Sellers outnumbered buyers: 164 funds closed out of BIIB and 119 opened new positions — a net loss of 45 holders — while 436 trimmed existing stakes and 391 added.

The largest buyer was AQR Capital Management, adding an estimated $335M. The largest seller was Ameriprise, cutting an estimated $509M.

  • 1,086 institutional investors held Biogen (BIIB) as of Q1 2019, down from 1,142 in Q4 2018.
  • Funds reported $40.8B of Biogen stock for Q1 2019, down 23% quarter-over-quarter.
  • 119 funds opened new Biogen positions in Q1 2019 and 164 closed out, a net change of -45 holders.
  • The largest Biogen buyer in Q1 2019 was AQR Capital Management, an estimated $335M added.
  • The largest Biogen seller in Q1 2019 was Ameriprise, an estimated $509M sold.

Based on aggregated 13F filings for Q1 2019.

Product
Portfolios Fund Managers Fund Trends Large Buys & Sells Signals Stocks ETFs Sectors Industries Themes Rankings
Popular funds
Jane Street Citadel Renaissance Situational Awareness Coatue Bridgewater Berkshire Appaloosa Pershing Square
Resources
API Docs Plans Learn Methodology
Policies
Terms & Conditions Privacy Policy Disclaimer Climate Commitment
Connect
Contact Us About X (Twitter) LinkedIn

© 2026 Wall St. Rank

Sign up Sign in
Common Fund Bets See what stocks and ETFs funds are collectively bullish/bearish on Largest Block Trades Explore the largest stock and ETF buys and sells made by funds High Conviction Trades Discover trades at least twice the size of a fund's median trade that quarter Fund Signals Daily bullish and bearish fund signals, and how past ones played out Fund Manager Portfolios Gain insights from the world’s largest funds and super investors Fund Flows Report Our quarterly report on what the world’s largest funds bought and sold Thematic Trends Track which investment themes funds are piling into or pulling out of
Institutional Conviction Index Stock index based on fund manager consensus updated each quarter

Theme